All In Biotech

Free tool

FAERS Monitor: Sodium Nitrite

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203922 or its brand name (Sodium Nitrite, Sodium Nitrite). Reports on generic versions are filed under their own applications.

Reports

57

Serious

56

98% of reports

Hospitalization

23

Death reported

39

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • completed suicide25
  • methaemoglobinaemia15
  • toxicity to various agents13
  • overdose8
  • suicide attempt7
  • cardiac arrest6
  • cyanosis6
  • drug ineffective6
  • hypoxia5
  • anoxia4
  • brain oedema4
  • cardiac failure acute3
  • cardio-respiratory arrest3
  • coma3
  • pulmonary haemorrhage3

Reports by year received

View as table
YearReports
20061
20121
20204
20218
202211
20238
20244
202515
20265

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,102 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anoxiaSignal44245.61640.612,848
methaemoglobinaemiaSignal152406.81555.833,492
cardiac failure acuteSignal3166.355.2341
pulmonary haemorrhageSignal3141.547.0290
cyanosisSignal6140.866.1699
brain oedemaSignal4117.045.5351
completed suicideSignal25110.782.52,620
hypoxiaSignal552.422.7204
suicide attemptSignal742.621.3245
toxicity to various agentsSignal1328.417.6320
cardiac arrestSignal626.812.6125
cardio-respiratory arrestSignal326.58.850
comaSignal323.27.744
overdoseSignal813.77.283
drug ineffective61.70.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.